Episode Details
Back to Episodes
Pharmaceutical Executive Daily: FDA Approves Auvelity
Published 2 weeks, 5 days ago
Description
In today's Pharmaceutical Executive Daily, the FDA's Oncologic Drugs Advisory Committee votes a favorable benefit-risk profile for AstraZeneca's Truqap, FDA approves Axsome Therapeutics' Auvelity, and Pharmaceutical Executive speaks with Jeff Golfman on how global disruptions are cascading through the pharmaceutical supply chain.